Fortrea Holdings (FTRE) Non-Current Assets (2022 - 2026)

Fortrea Holdings (FTRE) posted Non-Current Assets of $1.8 billion for Q1 2026, down 0.91% on a QoQ basis from $1.8 billion in Q4 2025, and down 16.22% year-over-year from $2.2 billion in Q1 2025.

Fortrea Holdings (FTRE) Non-Current Assets (2022 - 2026) Analysis & Trends

Fortrea Holdings' Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

  • Quarterly Non-Current Assets fell 16.22% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 billion (down 28.15% YoY) and the FY2025 annual result came in at $1.8 billion, down 30.88% from the prior year.
  • Non-Current Assets was $1.8 billion for Q1 2026 at Fortrea Holdings, down from $1.8 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.1 billion in Q2 2023 and bottomed at $1.8 billion in Q1 2026.
  • A 5-year average of $2.5 billion and a median of $2.7 billion in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets advanced 1.34% — and 2025, when it plunged 33.12%.
  • Fortrea Holdings' Non-Current Assets stood at $3.0 billion in 2022, then rose by 1.34% to $3.1 billion in 2023, then declined by 14.63% to $2.6 billion in 2024, then tumbled by 30.88% to $1.8 billion in 2025, then dropped by 0.91% to $1.8 billion in 2026.
  • Business Quant data shows FTRE's Non-Current Assets at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 1.80 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.80 Bn
Dec 31, 2025 1.82 Bn
Sep 30, 2025 1.82 Bn
Jun 30, 2025 1.88 Bn
Mar 31, 2025 2.15 Bn
Dec 31, 2024 2.63 Bn
Sep 30, 2024 2.73 Bn
Jun 30, 2024 2.68 Bn
Mar 31, 2024 3.04 Bn
Dec 31, 2023 3.08 Bn
Sep 30, 2023 3.06 Bn
Jun 30, 2023 3.12 Bn
Dec 31, 2022 3.04 Bn